Published in FEMS Microbiol Lett on October 15, 2000
Global transposon mutagenesis and essential gene analysis of Helicobacter pylori. J Bacteriol (2004) 3.25
Expanded metabolic reconstruction of Helicobacter pylori (iIT341 GSM/GPR): an in silico genome-scale characterization of single- and double-deletion mutants. J Bacteriol (2005) 2.82
A complete collection of single-gene deletion mutants of Acinetobacter baylyi ADP1. Mol Syst Biol (2008) 2.79
Genetic control of biosynthesis and transport of riboflavin and flavin nucleotides and construction of robust biotechnological producers. Microbiol Mol Biol Rev (2011) 1.38
The riboflavin transporter RibU in Lactococcus lactis: molecular characterization of gene expression and the transport mechanism. J Bacteriol (2006) 1.20
Biogeography of the intestinal mucosal and lumenal microbiome in the rhesus macaque. Cell Host Microbe (2015) 1.01
Riboflavin biosynthesis is associated with assimilatory ferric reduction and iron acquisition by Campylobacter jejuni. Appl Environ Microbiol (2007) 0.95
Helicobacter pylori FlhB function: the FlhB C-terminal homologue HP1575 acts as a "spare part" to permit flagellar export when the HP0770 FlhBCC domain is deleted. J Bacteriol (2006) 0.85
Global transcriptome analysis of Tropheryma whipplei in response to temperature stresses. J Bacteriol (2006) 0.84
Evolution of new function in the GTP cyclohydrolase II proteins of Streptomyces coelicolor. Biochemistry (2006) 0.84
Riboflavin level manipulates the successive developmental sequences in Aspergillus nidulans. Curr Microbiol (2015) 0.80
Description of a riboflavin biosynthetic gene variant prevalent in the phylum Proteobacteria. J Bacteriol (2013) 0.80
Improving the Clostridium acetobutylicum butanol fermentation by engineering the strain for co-production of riboflavin. J Ind Microbiol Biotechnol (2010) 0.79
Structural basis for competitive inhibition of 3,4-dihydroxy-2-butanone-4-phosphate synthase from Vibrio cholerae. J Biol Chem (2015) 0.77
Allelic diversity and recombination in Campylobacter jejuni. J Bacteriol (2001) 2.61
Antibody response of patients against a 120 kDa surface protein of Campylobacter pylori. Zentralbl Bakteriol Mikrobiol Hyg A (1988) 2.18
Helicobacter pylori activates mitogen-activated protein kinase cascades and induces expression of the proto-oncogenes c-fos and c-jun. J Biol Chem (2000) 1.97
Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut (2007) 1.85
Characterization of pili associated with Escherichia coli O18ac. Infect Immun (1980) 1.80
Purification of Helicobacter pylori superoxide dismutase and cloning and sequencing of the gene. Infect Immun (1993) 1.78
Comparison of different DNA fingerprinting techniques for molecular typing of Bartonella henselae isolates. J Clin Microbiol (1998) 1.77
Regulation of ferritin-mediated cytoplasmic iron storage by the ferric uptake regulator homolog (Fur) of Helicobacter pylori. J Bacteriol (2000) 1.66
Rapid and specific detection of Helicobacter pylori macrolide resistance in gastric tissue by fluorescent in situ hybridisation. Gut (2000) 1.62
Nickel-responsive induction of urease expression in Helicobacter pylori is mediated at the transcriptional level. Infect Immun (2001) 1.59
Proteins encoded by the cag pathogenicity island of Helicobacter pylori are required for NF-kappaB activation. Infect Immun (1998) 1.58
Derivation and validation of guidelines for stool cultures for enteropathogenic bacteria other than Clostridium difficile in hospitalized adults. JAMA (2001) 1.53
Identification and analysis of a new vacA genotype variant of Helicobacter pylori in different patient groups in Germany. J Clin Microbiol (1998) 1.51
Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. Eur J Clin Microbiol Infect Dis (2000) 1.45
Bacterial genetic fingerprint: a reliable factor in the study of the epidemiology of human campylobacter enteritis? J Clin Microbiol (2001) 1.44
Serodiagnosis of Helicobacter pylori infections with an enzyme immunoassay using the chromatographically purified 120 kilodalton protein. Eur J Clin Microbiol Infect Dis (1992) 1.35
Isolation of Helicobacter pullorum from patients with enteritis. Scand J Infect Dis (1997) 1.34
Small intestinal bacterial overgrowth in patients with cirrhosis: prevalence and relation with spontaneous bacterial peritonitis. Am J Gastroenterol (2001) 1.32
Molecular analysis of riboflavin synthesis genes in Bartonella henselae and use of the ribC gene for differentiation of Bartonella species by PCR. J Clin Microbiol (1999) 1.26
Campylobacter jejuni. Contrib Microbiol (2001) 1.25
Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune responses. Eur J Microbiol Immunol (Bp) (2012) 1.24
A secreted/shed product of Helicobacter pylori activates transcription factor nuclear factor-kappa B. J Immunol (1997) 1.17
What you eat is what you get: Novel Campylobacter models in the quadrangle relationship between nutrition, obesity, microbiota and susceptibility to infection. Eur J Microbiol Immunol (Bp) (2011) 1.15
Cloning and characterization of the fur gene from Helicobacter pylori. FEMS Microbiol Lett (1998) 1.14
Hemin-dependent growth and hemin binding of Bartonella henselae. FEMS Microbiol Lett (2000) 1.13
Increased number of Clostridium difficile infections and prevalence of Clostridium difficile PCR ribotype 001 in southern Germany. Euro Surveill (2008) 1.12
Identification of iron-regulated genes of Helicobacter pylori by a modified fur titration assay (FURTA-Hp). FEMS Microbiol Lett (2000) 1.12
Structural, functional and mutational analysis of the pfr gene encoding a ferritin from Helicobacter pylori. Microbiology (1998) 1.11
Molecular characterization of field isolates of Pseudomonas syringae pv. glycinea differing in coronatine production. J Gen Microbiol (1993) 1.09
Elevated risk of Helicobacter pylori infection in submarine crews. Eur J Clin Microbiol Infect Dis (1992) 1.09
Visualization of capsule formation by Erwinia amylovora and assays to determine amylovoran synthesis. Int J Biol Macromol (1994) 1.08
The ferric uptake regulator (Fur) homologue of Helicobacter pylori: functional analysis of the coding gene and controlled production of the recombinant protein in Escherichia coli. Med Microbiol Immunol (1999) 1.02
Seroepidemiological study of the immune response to Campylobacter pylori in potential risk groups. Eur J Clin Microbiol Infect Dis (1989) 1.00
Conjunctival infestation of a child with Theromyzon tessulatum. Br J Ophthalmol (1998) 1.00
In situ localization of the 60 k protein of Helicobacter pylori, which belongs to the family of heat shock proteins, by immuno-electron microscopy. Zentralbl Bakteriol (1993) 0.98
The role of Helicobacter pylori virulence factors in interleukin production by monocytic cells. FEMS Microbiol Lett (2001) 0.98
Cryptosporidia in immunocompetent patients with gastroenteritis. Eur J Clin Microbiol (1987) 0.97
[S3-guideline "Helicobacter pylori and gastroduodenal ulcer disease"]. Z Gastroenterol (2009) 0.96
Campylobacter jejuni induces extra-intestinal immune responses via Toll-like-receptor-4 signaling in conventional IL-10 deficient mice with chronic colitis. Eur J Microbiol Immunol (Bp) (2012) 0.96
Identification of environmental stress-regulated genes in Helicobacter pylori by a lacZ reporter gene fusion system. Helicobacter (2001) 0.93
The distinct roles of MMP-2 and MMP-9 in acute DSS colitis. Eur J Microbiol Immunol (Bp) (2011) 0.93
Discrimination of Helicobacter pullorum and Campylobacter lari by analysis of whole cell fatty acid extracts. FEMS Microbiol Lett (1998) 0.93
Can microbiota transplantation abrogate murine colonization resistance against Campylobacter jejuni? Eur J Microbiol Immunol (Bp) (2013) 0.93
Recognition of Clostridium difficile PCR-ribotypes 001, 027 and 126/078 using an extended MALDI-TOF MS system. Eur J Clin Microbiol Infect Dis (2011) 0.92
[Networks of National Reference Centers and associated Consiliary Laboratories in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2012) 0.91
Diagnosis of small intestinal bacterial overgrowth in patients with cirrhosis of the liver: poor performance of the glucose breath hydrogen test. J Hepatol (2000) 0.90
[Establishment of Networks of National Reference Centres and associated Consiliary Laboratories in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2009) 0.90
[Infections caused by Campylobacter jejuni/coli]. Dtsch Med Wochenschr (1983) 0.90
Association of ciprofloxacin prescriptions to outpatients to Clostridium difficile infections. Euro Surveill (2010) 0.87
Detection of antibodies against Campylobacter jejuni serogroup PEN O:19 purified flagellar protein in a patient with Guillain-Barré syndrome. Zentralbl Bakteriol (1999) 0.87
[Campylobacteriosis of man : livestock as reservoir for Campylobacter species]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz (2011) 0.87
[Who discovered Campylobacter jejuni/coli? A review of hitherto disregarded literature]. Zentralbl Bakteriol Mikrobiol Hyg A (1986) 0.86
Seasonality of Clostridium difficile infections in Southern Germany. Epidemiol Infect (2011) 0.86
Selective gelatinase blockage ameliorates acute DSS colitis. Eur J Microbiol Immunol (Bp) (2011) 0.86
Helicobacter pylori eradication and gastric ulcer healing--comparison of three pantoprazole-based triple therapies. Aliment Pharmacol Ther (2003) 0.86
Immunological reaction of guinea-pigs following intranasal Mycoplasma pneumoniae infection and immunization with the 168 kDa adherence protein. J Gen Microbiol (1988) 0.85
Selective gelatinase inhibition reduces apoptosis and pro-inflammatory immune cell responses in Campylobacter jejuni-infected gnotobiotic IL-10 deficient mice. Eur J Microbiol Immunol (Bp) (2014) 0.85
Mesenteric fat - control site for bacterial translocation in colitis? Mucosal Immunol (2012) 0.85
New approaches for genotyping of Helicobacter pylori based on amplification of polymorphisms in intergenic DNA regions and at the insertion site of the cag pathogenicity island. Med Microbiol Immunol (2000) 0.85
Eradication of H. pylori with pantoprazole, clarithromycin, and metronidazole in duodenal ulcer patients: a head-to-head comparison between two regimens of different duration. Helicobacter (2000) 0.85
Identification and molecular analysis of superoxide dismutase isoforms in Helicobacter pylori. FEMS Microbiol Lett (2000) 0.83
Hemolytic properties and riboflavin synthesis of Helicobacter pylori: cloning and functional characterization of the ribA gene encoding GTP-cyclohydrolase II that confers hemolytic activity to Escherichia coli. Med Microbiol Immunol (1998) 0.82
Routine identification of Campylobacter jejuni and Campylobacter coli from human stool samples. FEMS Microbiol Lett (1999) 0.82
Is Helicobacter pylori resident or transient in the human oral cavity? J Med Microbiol (2012) 0.82
Host reactions to Mycoplasma pneumoniae infections in guinea-pigs preimmunized systemically with the adhesin of this pathogen. Microb Pathog (1988) 0.81
Differences in the isoelectric focussing pattern of antibodies to human serum albumin eluted from an immunoadsorbent (HSA-sepharose) with thiocyanate ions. Res Exp Med (Berl) (1978) 0.81
Pro-inflammatory potential of Escherichia coli strains K12 and Nissle 1917 in a murine model of acute ileitis. Eur J Microbiol Immunol (Bp) (2013) 0.81
Phagocytosis and complement action. Isr J Med Sci (1981) 0.81
Helicobacter pylori infection does not correlate with plasma ammonia concentration and hepatic encephalopathy in patients with cirrhosis. Hepatogastroenterology (2001) 0.81
Campylobacter coli septicaemia associated with septic abortion. Infection (1984) 0.80
High prevalence of antibodies to calreticulin of the IgA class in primary biliary cirrhosis: a possible role of gut-derived bacterial antigens in its aetiology? Scand J Gastroenterol (1999) 0.80
Release of Mycoplasma pneumoniae substances after phagocytosis by guinea pig alveolar macrophages. Infect Immun (1982) 0.78
Susceptibility in vitro of Helicobacter pylori to cetylpyridinium chloride. FEMS Immunol Med Microbiol (1999) 0.78
[Clostridium difficile infection]. Dtsch Med Wochenschr (2010) 0.77
[Emergence of clostridium difficile ribotype 027 in Germany: epidemiological and clinical characteristics]. Z Gastroenterol (2010) 0.77
Nahua indian medicinal plants (Mexico): Inhibitory activity on NF-κB as an anti-inflammatory model and antibacterial effects. Phytomedicine (1996) 0.77
Antimicrobial resistance in Escherichia coli strains isolated from food, animals and humans in Germany. Infection (2007) 0.77
Cloning and functional characterization of the genes encoding 3-dehydroquinate synthase (aroB) and tRNA-guanine transglycosylase (tgt) from Helicobacter pylori. Med Microbiol Immunol (1997) 0.77
Mycoplasma pneumoniae induces cytotoxic activity in guinea pig bronchoalveolar cells. Am Rev Respir Dis (1985) 0.76
The synthetic hydroxyproline-containing collagen analogue (Gly-Pro-Hyp)10 ameliorates acute DSS colitis. Eur J Microbiol Immunol (Bp) (2012) 0.75
Clinical significance of pure or predominant growth of Pseudomonas aeruginosa in faecal specimens of medical patients. J Hosp Infect (1999) 0.75
[Consider a campylobacter infection more frequently. The underestimated intestinal pathogen (interview by Michael Koczorek)]. MMW Fortschr Med (2001) 0.75
Encephalopathy associated with Yersinia enterocolitica O:3. Lancet (1998) 0.75
Correlations between bed occupancy rates and Clostridium difficile infections: a time-series analysis. Epidemiol Infect (2010) 0.75
Antibiotic-associated diarrhea: therapeutic aspects and practical guidelines--an interdisciplinary approach to a common problem. Praxis (Bern 1994) (2003) 0.75
Asymmetric synthesis and structure-activity relationship of the four stereoisomers of the antibiotic amidinomycin. Part 2: Microbiological testing. Arch Pharm (Weinheim) (1997) 0.75
Clinical microbiological case: a 35-year-old HIV-positive man with intermittent fever and chronic diarrhea. Clin Microbiol Infect (2000) 0.75
[Infections due to Yersinia enterocolitica]. Med Klin (1979) 0.75
Culture and successful eradication of Helicobacter pylori from heterotopic gastric mucosa. Z Gastroenterol (2012) 0.75
[Nosocomial diarrhea]. Dtsch Med Wochenschr (2001) 0.75
Antibiotic-associated diarrhea: incidence, risk factors of antibiotics and patients, pathophysiology and differential diagnosis--an interdisciplinary approach to a common problem. Praxis (Bern 1994) (2003) 0.75